Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Condition: Atopic Dermatitis Interventions: Drug: Tralokinumab; Drug: Placebo; Biological: Tdap vaccine; Biological: Meningococcal vaccine Sponsor: LEO Pharma Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials